Geron
Markets RYTELO, the only approved telomerase inhibitor, for transfusion-dependent low-risk MDS patients.
$1.51
After-hours close+0.01 (+0.33%)
At close$1.51(−1.63%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.01 | — | — |
| Aug 2026 | −$0.01 | −$0.02 | −125.2% |
| May 2026 | −$0.03 | −$0.01 | +66.7% |
| Feb 2026 | −$0.03 | −$0.03 | 0.0% |
| Nov 2025 | −$0.04 | −$0.03 | +18.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Jul 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$0.01 | — | — | $60.7M | — | — |
| Aug 5, 2026 | −$0.01 | −$0.02 | −125.2% | $55.3M | $57.5M | +3.9% |
| May 6, 2026 | −$0.03 | −$0.01 | +66.7% | $50.6M | $51.8M | +2.5% |
| Feb 25, 2026 | −$0.03 | −$0.03 | 0.0% | $50.4M | $48.0M | −4.8% |
| Nov 5, 2025 | −$0.04 | −$0.03 | +18.2% | $53.3M | $47.2M | −11.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 6, 2025 | ||||||
| May 7, 2025 | ||||||
| Feb 26, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 2, 2024 | ||||||
| Feb 28, 2024 | ||||||
| Nov 2, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 11, 2023 | ||||||
| Mar 16, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 9, 2022 | ||||||
| Mar 10, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 16, 2021 | ||||||
| May 10, 2021 | ||||||
| Mar 11, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 28, 2020 | ||||||
| Mar 12, 2020 | ||||||
| Nov 6, 2019 | ||||||
| Aug 1, 2019 | ||||||
| May 2, 2019 | ||||||
| Mar 7, 2019 | ||||||
| Nov 1, 2018 | ||||||
| Jul 31, 2018 | ||||||
| May 10, 2018 | ||||||
| Mar 16, 2018 | ||||||
| Nov 1, 2017 | ||||||
| Aug 9, 2017 | ||||||
| May 9, 2017 | ||||||
| Mar 1, 2017 | ||||||
| Nov 3, 2016 | ||||||
| Aug 3, 2016 | ||||||
| May 5, 2016 | ||||||
| Feb 25, 2016 | ||||||
| Nov 5, 2015 | ||||||
| Aug 5, 2015 | ||||||